An experimental treatment combining gene therapy with specialized goggles has helped some people with advanced blindness ...

Donald Walton has asked local elected officials in the Town of Edinburg to erect cautionary signage for drivers in his ...

Tested on an unexpected source, this treatment could repair mammalian nerve cells — a feat once thought impossible.

Jason Horek said he took Wegovy to lose a few pounds. Months later, he was diagnosed with a rare eye condition that left him with permanent vision loss in one eye, a condition researchers are studying ...

Even though studies have linked GLP-1s to development of nonarteritic anterior ischemic neuropathy, the risk is not great enough to warrant stopping the medication, according to a speaker at Academy ...

British research involving almost 1,000 patients found that about a fifth encountered treatments they deemed fraudulent. The majority of patients said they'd skipped these types of "treatments," ...

Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.

Over 200 federal lawsuits allege GLP-1 drugs like Ozempic and Mounjaro caused NAION, a rare permanent vision loss condition, with manufacturers disputing the claims.

Glucagon-like peptide-1 (GLP-1) receptor agonists have transformed treatment of diabetes and obesity, with positive effects reported on cardiovascular events, blood pressure, cholesterol levels and ...

Health headlines for Wednesday, Sept. 23 include GLP-1 vision loss lawsuits, a new Alzheimer's brain map and ibogaine under scrutiny. (Adobe Stock Photo) ...

She was taking a GLP-1 drug to lose weight when she woke up one morning with vision loss in her right eye. “It’s been very challenging,” she says. Here’s what doctors say about the risk. Hundreds of ...

Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss. The patients behind the lawsuits allege that ...